Hindson Benjamin J. sold $871K of TXG
Hindson Benjamin J. (See Remarks) sold 13,818 shares of 10x Genomics, Inc. (TXG) at $63.02 ($0.87M total) on 2026-08-24.
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 26, 2026, 9:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TXG
Neutral
medium confidence
Mentioned
$TXG
Relevance
5/10
Decision brief
The 30-second read
01
Why it matters
The insider sale is a routine transaction with limited market impact.
02
Market read
Small insider sale; unlikely to move the stock significantly.
03
Timing
post-market 2026-08-24
Relevance 5/10Novelty 4/10Timing: post-market 2026-08-24
Background
Form 4 filing discloses insider transaction for 10x Genomics.
Company-level read
Ticker impact
Context
Officer/director Hindson sold 13,818 shares for $870,860, reducing his stake to 488,182 shares.
Expected impact
Potential modest downside pressure in short term.
Evidence & confidence
The sale size (~$0.87M) is small relative to market cap; impact likely limited.
Key entities
- Officer/DirectorHindson Benjamin J.
Insider selling shares of TXG.
- Company10x Genomics, Inc.
Biotech firm listed on NASDAQ under ticker TXG.
